The latest trading day saw Oscar Health, Inc. (OSCR) settling at $14.17, representing a -0.07% change from its previous close.
In the most recent trading session, Oscar Health, Inc. (OSCR) closed at $13.44, indicating a -1.03% shift from the previous trading day.
The latest trading day saw Oscar Health, Inc. (OSCR) settling at $13.58, representing a -1.59% change from its previous close.
The latest trading day saw Oscar Health, Inc. (OSCR) settling at $13.50, representing a +0.9% change from its previous close.
Mark Bertolini, Oscar Health CEO and former Aetna chairman and CEO, joins 'Squawk Box' to discuss the state of the health insurance industry in the wake of the killing of UnitedHealthcare CEO Brian Th
After UnitedHealthcare (UNH) CEO Brian Thompson was fatally shot in New York City last week, various health insurance providers have removed executives' biography pages from the corporate websites. NY
Mark Bertolini, Oscar Health CEO, joins 'Squawk Box' to discuss what the new administration means for the health care sector, ways to roll back parts of Obamacare, and much more.
NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, today announced that the Anahata Foundation (“Anahata”), a charitable foundation
24/7 Wall St. Insights As we race toward the end of the year, the past week brought some huge insider share purchases.
NEW YORK--(BUSINESS WIRE)--Oscar Health, Inc. (“Oscar”) (NYSE: OSCR), a leading healthcare technology company, today announced it will bring the Oscar experience to more individuals, families, and
Oscar Health (OSCR) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Start Time: 08:00 January 1, 0000 8:36 AM ET Oscar Health, Inc. (NYSE:OSCR ) Q3 2024 Earnings Call November 07, 2024, 08:00 AM ET Company Participants Mark Bertolini - CEO Scott Blackley - Chief Finan
Oscar Health, Inc. (OSCR) came out with a quarterly loss of $0.22 per share versus the Zacks Consensus Estimate of a loss of $0.20. This compares to loss of $0.29 per share a year ago.
NEW YORK--(BUSINESS WIRE)--Oscar Health Announces Results for Third Quarter 2024.
Oscar Health Thursday reported a $54 million third quarter loss despite continued growth, heading into what could be an uncertain political period under Donald Trump and Republicans in Congress.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE